Rubius Therapeutics Inc. Shares Close the Week 54.0% Higher - Weekly Wrap

The company saw its shares close the week 54.0% higher than last week, with trading volume higher than its 30 day average.

Mar 19, 2021 by Kwhen Finance Editors

Rubius Therapeutics Inc. Shares Close the Week 54.0% Higher - Weekly Wrap
Rubius Therapeutics Inc. shares closed this week 54.0% higher than it did at the end of last week. The stock is currently up 233.5% year-to-date, up 502.6% over the past 12 months, and up 4.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%.

Trading Activity

  • Shares traded as high as $38.71 and as low as $17.86 this week.
  • Shares closed 3e+1% below its 52-week high and 6e+2% above its 52-week low.
  • Trading volume this week was 59.2% lower than the 10-day average and 5.2% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.9.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was between 30 and 70.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.
  • The stock closed at 7.0% lower than its 5-day moving average, 59.7% higher than its 20-day moving average, and 144.4% higher than its 90-day moving average.

Market Comparative Performance

  • The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Rubius Therapeutics Inc.4.3233.5502.6-37.1536.0
Dow Jones Industrial Average-0.87.165.7-1.283.8
S&P 500 Index-0.24.565.5-1.781.5
Health Care0.51.545.7-4.061.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 330.9%
  • The company's stock price performance over the past 12 months beats the peer average by 254.3%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Rubius Therapeutics Inc.RUBY0233.5502.6-37.1536.0
Peer AvgN/A054.2141.9-25.5213.6
Ocular Therapeutix IncOCUL0-0.1335.2-19.5378.2
OncoCyte Corp.OCX0101.0141.5-30.3298.3
Oragenics Inc.OGEN0115.890.8-52.2177.8

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: